Examinant per Autoria "Rodriguez-Vida, Alejo"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Apalutamide for prostate cancer: Multicentre and multidisciplinary real-world study of 227 patients(Wiley, 2023) Córdoba Sánchez, Julián; Picola, Natàlia; Rodriguez-Vida, Alejo; Costa, Marc; Marmolejo Castañeda, David; Pérez Márquez, Meritxell; Muñoz Rodriguez, Jesús; Gaya Sopena, Josep Maria; Bravo, Alejandra; Buisan, Oscar; Servian, Pol; Suárez Novo, José Francisco; Musquera Felip, Mireia; Ribal Caparrós, Maria Jose; Alcaraz Asensio, Antonio; Vilaseca, Antoni
Ítem Accés Obert Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors(Wiley, 2024) Robbrecht, Debbie; Rodriguez-Vida, Alejo; Wang, Rui
Ítem Accés Obert Cell plasticity-related phenotypes and taxanes resistance in castration-resistant prostate cáncer(Frontiers, 2020) Jiménez, Natalia; Reig, Òscar; Montalbo, Ruth; Milà-Guasch, Maria; Nadal-Dieste, Lluis; Castellano, Giancarlo; Lozano, Juan José; Victoria, Iván; Font, Albert; Rodriguez-Vida, Alejo; Carles, Joan; Suárez, Cristina; Doménech, Montserrat; Sala-González, Núria; Fernández, Pedro Luís; Rodríguez-Carunchio, Leonardo; Díaz, Sherley; Prat, Aleix; Marín-Aguilera, Mercedes; Mellado, Begoña
Ítem Accés Obert Complexity of FGFR signalling in metastatic urothelial cancer.(BioMed Central, 2015) Rodriguez-Vida, Alejo; Saggese, Matilde; Hughes, Simon; Rudman, Sarah; Chowdhury, Simon; Smith, Neil R.; Lawrence, Peter; Rooney, Claire; Dougherty, Brian; Landers, Donal; Kilgour, Elaine; Arkenau, Hendrik-Tobias
Ítem Accés Obert Development and independent validation of a prognostic gene expression signature based on RB1, PTEN, and TP53 in metastatic hormone-sensitive prostate cancer patients(Elsevier, 2024) Jiménez, Natalia; Rodriguez-Vida, Alejo; Mellado, Begoña
Ítem Accés Obert Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosis(Wiley, 2023) Del Carpio, Luis P.; Algarra, María Asunción; Sabaté-Llobera, Aida; Rodriguez-Vida, Alejo; Rossi-Seoane, Susana; Ruiz, Sandra; Leiva, David; Ramos, Emilio; Lladò, Laura; Lorenzo, Daniel; Gutiérrez, Cristina; Cortes-Romera, Montserrat; Caminal, Josep Maria; Piulats, Josep Maria
Ítem Accés Obert Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)(BioMed Central, 2021) Grivas, Petros; Rodriguez-Vida, Alejo; Chowdhury, Simon
Ítem Accés Obert Genomic predictors of good outcome, recurrence, or progression in high-grade T1 non-muscle-invasive bladder cancer(American Association for Cancer Research (AACR), 2020) Bellmunt Molins, Joaquim, 1959-; Perera Bel, Júlia; Orsola, Anna; Rodriguez-Vida, Alejo; Juanpere, Nuria; Lloreta, Josep, 1958-; Hernández, Silvia; Kwiatkowski, David J.
Ítem Accés Obert Immunohistochemical markers as predictors of prognosis in multifocal prostate cancer(Springer, 2024) Segalés Tañà, Laura, 1994-; Juanpere, Nuria; Gallarín, Nerea; Lorenzo Perez, Marta; López Martos, David; Perera Bel, Júlia; Rodriguez-Vida, Alejo; Fumadó Ciutat, Lluis; Cecchini Rosell, Lluís; Bellmunt Molins, Joaquim, 1959-; Lloreta, Josep, 1958-; Hernández Llodrà, Silvia
Ítem Accés Obert Impact of new systemic therapies in overall survival in non-metastatic castration resistant prostate cancer: systematic review and meta-analysis(Elsevier, 2022) Rodriguez-Vida, Alejo; Rodríguez-Alonso, Andrés; Useros-Rodríguez, Eduardo; Lopez-Campos, Fernando; Amor-Carro, Oscar; Arribas-Ruiz, Alberto; Martínez-Torres, Javier; Roca-Pardiñas, Javier; Quesada-García, Alba; Muñoz-Del-Toro, Jacobo R.; Juárez-Soto, Álvaro
Ítem Accés Obert Metastatic calcinosis cutis secondary to selective fibroblast growth factor receptor inhibitor: rapid and complete regression after blood phosphate normalization and drug withdrawal(Society for Publication of Acta Dermato-Venereologica, 2020) López-Castillo, Daniel; March-Rodríguez, Alvaro; Rodriguez-Vida, Alejo; Pujol Vallverdú, Ramon Maria; Segura Tigell, Sonia
Ítem Accés Obert New treatment options for metastatic renal cell carcinoma(BMJ Publishing Group, 2017) Hutson, Thomas E.; Bellmunt Molins, Joaquim, 1959-; Strijbos, Michiel H.; Rodriguez-Vida, Alejo
Ítem Accés Obert Novel oral mTORC1/2 inhibitor TAK-228 has synergistic antitumor effects when combined with paclitaxel or PI3Kα inhibitor TAK-117 in preclinical bladder cancer models(American Association for Cancer Research (AACR), 2019) Hernández Prat, Anna, 1984-; Rodriguez-Vida, Alejo; Juanpere, Nuria; Arpí Llucià, Oriol; Menéndez, Silvia; Soria-Jiménez, Luis; Martínez, Alejandro; Iarchouk, Natalia; Rojo, Federico; Albanell Mestres, Joan; Brake, Rachael; Rovira Guerín, Ana; Bellmunt Molins, Joaquim, 1959-
Ítem Accés Obert Pharmacokinetics (PK) of tiragolumab in first-in-human study in patients with mixed solid tumors (GO30103)(Wiley, 2024) Garralda, Elena; Oh, Do Youn; Italiano, Antoine; Bedard, Philippe L.; Delord, Jean-Pierre; Calvo, Emiliano; LoRusso, Patricia; Wainberg, Zev A.; Cervantes, Andrés; Rodriguez-Vida, Alejo; Shemesh, Colby S.; Sane, Rucha; Mendus, Diana; Ding, Hao; Hendricks, Robert; Meng, Ray; Cho, Byoung Chul; Kim, Tae Won; Wu, Benjamin
Ítem Accés Obert Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma(BMJ Publishing Group, 2017) Rodriguez-Vida, Alejo; Strijbos, Michiel H.; Hutson, Thomas Xavier
Ítem Accés Obert Prognostic value of the lung immune prognosis index score for patients treated with immune checkpoint inhibitors for advanced or metastatic urinary tract carcinoma(MDPI, 2023) Parent, Pauline; Auclin, Edouard; Patrikidou, Anna; Mezquita, Laura; Martínez Chanzá, Nieves; Dumont, Clement; Rodriguez-Vida, Alejo; Llacer, Casilda; Lozano, Rebeca; Ratta, Raffaele; Merseburger, Axel S.; Sternberg, Cora N.; Baciarello, Giulia; Colomba, Emeline; Fuerea, Alina; Besse, Benjamin; Loriot, Yohann; Lavaud, Pernelle
Ítem Accés Obert The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer(Nature Research, 2023) Boll, Lilian Marie; Perera Bel, Júlia; Rodriguez-Vida, Alejo; Arpí Llucià, Oriol; Rovira, Ana; Juanpere, Nuria; Vázquez Montes de Oca, Sergio; Hernández Llodrà, Silvia; Lloreta, Josep, 1958-; Albà Soler, Mar; Bellmunt Molins, Joaquim, 1959-
Ítem Accés Obert Treatment of non-metastatic castration-resistant prostate càncer. Facing age-related comorbidities and drug-drug interactions(Informa Healthcare, 2022) Conde Estévez, David; Henríquez, Iván; Muñoz-Rodríguez, Jesús; Rodriguez-Vida, Alejo
Ítem Accés Obert Treatments outcomes in histological variants and non-urothelial bladder cancer: results of a multicenter retrospective study(Frontiers, 2021) Epaillard, Nicolas; Parent, Pauline; Loriot, Yohann; Lavaud, Pernelle; Vera-Cea, E-B; Martinez-Chanza, Nieves; Rodriguez-Vida, Alejo; Dumont, Clement; Lozano, Rebeca; Llácer, Casilda; Ratta, Raffaele; Oudard, Stephane; Thibault, Constance; Auclin, Edouard